Ovizio

News

Ovizio wins the Deloitte Benelux Most Disruptive innovator 2012 Award.

Ovizio and Applikon Biotechnology sign long term agreement.

Why choosing our technology

① Label free

② No sample preparation

③ Real-time

④ Non-invasive

⑤ Quantitative

Realized with the help of Brussels Export